HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You can speak English or Spanish
- You are willing and able to sign a consent form, share your contact information, and allow access to your medical records
- You tested negative for HIV on a rapid HIV test
- You have used a syringe services program (a place to exchange needles) at least 2 times in the past 3 months
- You plan to stay in the local area for the next 12 months
Who may not be able to join:
- You tested positive for HIV
- You are currently taking medications to treat opioid use disorder, as shown by a urine drug test
- You are currently taking PrEP (a medication to prevent HIV), based on what you tell the study team
- The study doctors or investigators decide, for any reason, that participation is not appropriate for you (confirm with trial site)
- You are currently in prison or jail
- You are currently taking part in another specific study called Clinical Trials Network 121
- You have received tele-harm reduction services (harm reduction support delivered remotely, such as by phone or video) in the past 3 months
- You currently have signs or symptoms that suggest you may have a new or recent HIV infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hansel Tookes, MD, University of Miami
Phone: 3052431615
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
HIV prevention via pre-exposure prophylaxis (PrEP); HIV prevention via medications for opioid use disorder
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.